The Relief Initiative: Evolving Concepts in Diabetes Management: Practical Tools for Integrating GLP-1 Receptor Agonists for Improved Glycemic Control
Robert Busch, MD
Endocrinology, Diabetes, & Metabolism
AMC Community Division
The Endocrine Group
Albany, New York
Dhiren Patel, PharmD, CDE, BC-ADM, BCACP
Clinical Pharmacy Specialist – Endocrine
VA Boston Healthcare System
Adjunct Associate Professor of Pharmacy Practice
Javier Morales, M.D., F.A.C.P., F.A.C.E.
Associate Clinical Professor of Medicine
Northwell Hofstra School of Medicine
This case-based enduring activity will cover the treatment and management of patients with diabetes.
This educational activity is intended for primary care physicians, physician assistants, nurse practitioners, pharmacists, certified diabetes educators, and other HCPs who care for patients with diabetes.
Upon completion of the program, attendees should be able to:
- Evaluate the physiological role of GLP-1 and associated implications for the treatment of patients with diabetes.
- Review recommendations from current diabetes guidelines regarding the use of GLP-1 receptor agonists.
- Determine the advantages and disadvantages of individual GLP-1 receptor agonists in terms of efficacy, tolerability, dosing frequency, and administration requirements.
- Assess the effect of GLP-1 receptor agonists on glycemic and extraglycemic outcomes.
- Discuss strategies for reducing adverse effects in patients receiving GLP-1 receptor agonists.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
This program would be beneficial for nurses involved in treating and managing patients with diabetes.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.0 contact hours of continuing nursing education for RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Dr. Busch reports that he has served on speaker’s bureau Novo Nordisk, Lilly, Amgen, Astra-Zeneca, Sanofi, and Boehringer Ingelheim. In addition, he has research grants Novo Nordisk, Lilly, Sanofi, Astra-Zeneca, Kowa Pharma, and Gilead.
Dr. Patel reports that he has served as a speaker’s bureau for Astra Zeneca, Boehringer Ingelheim, Merck, Novo Nordisk, and Valeritas. He has served as a consultant for Astra Zeneca, Becton Dickinson, Boehringer Ingelheim, Eli Lilly, Merck, Novo Nordisk, and Sanofi.
Javier Morales, MD reports that he has served as a consultant and speakers bureau for Novo Nordisk, Lilly, Boehringer-Ingelheim Pharmaceuticals, AstraZeneca, Mylan, and Abbott.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer-reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Sharine Griggs, Program Manager for Med Learning Group, has nothing to disclose.
Ana Maria Albino, Program Manager for Med Learning Group, has nothing to disclose.
Diana Tommasi, Scientific and Medical Services for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, faculty may mention the use of medications for both FDA-approved and nonapproved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this live activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Submit the evaluation form to the Med Learning Group.
Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
RELEASE DATE: January 9, 2020
EXPIRATION DATE: January 9, 2021
Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.